Moira Rachman, PhD

Title(s)Postdoctoral Scholar, Pharmaceutical Chemistry
SchoolSchool of Pharmacy
Address555 Mission Bay Blvd South, #001
San Francisco CA 94158
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. The Mac1 ADP-ribosylhydrolase is a Therapeutic Target for SARS-CoV-2. bioRxiv. 2024 Aug 29. Suryawanshi RK, Jaishankar P, Correy GJ, Rachman MM, O'Leary PC, Taha TY, Zapatero-Belinchón FJ, McCavittMalvido M, Doruk YU, Stevens MGV, Diolaiti ME, Jogalekar MP, Richards AL, Montano M, Rosecrans J, Matthay M, Togo T, Gonciarz RL, Gopalkrishnan S, Neitz RJ, Krogan NJ, Swaney DL, Shoichet BK, Ott M, Renslo AR, Ashworth A, Fraser JS. PMID: 39149230; PMCID: PMC11326214.
      View in: PubMed   Mentions:
    2. Extensive exploration of structure activity relationships for the SARS-CoV-2 macrodomain from shape-based fragment merging and active learning. bioRxiv. 2024 Aug 26. Correy GJ, Rachman M, Togo T, Gahbauer S, Doruk YU, Stevens M, Jaishankar P, Kelley B, Goldman B, Schmidt M, Kramer T, Ashworth A, Riley P, Shoichet BK, Renslo AR, Walters WP, Fraser JS. PMID: 39253507; PMCID: PMC11383323.
      View in: PubMed   Mentions:
    3. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc Natl Acad Sci U S A. 2023 01 10; 120(2):e2212931120. Gahbauer S, Correy GJ, Schuller M, Ferla MP, Doruk YU, Rachman M, Wu T, Diolaiti M, Wang S, Neitz RJ, Fearon D, Radchenko DS, Moroz YS, Irwin JJ, Renslo AR, Taylor JC, Gestwicki JE, von Delft F, Ashworth A, Ahel I, Shoichet BK, Fraser JS. PMID: 36598939; PMCID: PMC9926234.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCellsPHPublic Health
    4. Ligand recognition and allosteric modulation of the human MRGPRX1 receptor. Nat Chem Biol. 2023 04; 19(4):416-422. Liu Y, Cao C, Huang XP, Gumpper RH, Rachman MM, Shih SL, Krumm BE, Zhang S, Shoichet BK, Fay JF, Roth BL. PMID: 36302898.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    5. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 Macrodomain of SARS-CoV-2. bioRxiv. 2022 Jul 28. Gahbauer S, Correy GJ, Schuller M, Ferla MP, Doruk YU, Rachman M, Wu T, Diolaiti M, Wang S, Neitz RJ, Fearon D, Radchenko D, Moroz Y, Irwin JJ, Renslo AR, Taylor JC, Gestwicki JE, von Delft F, Ashworth A, Ahel I, Shoichet BK, Fraser JS. PMID: 35794891; PMCID: PMC9258288.
      View in: PubMed   Mentions:
    6. Discovery of Novel BRD4 Ligand Scaffolds by Automated Navigation of the Fragment Chemical Space. J Med Chem. 2021 12 23; 64(24):17887-17900. Piticchio SG, Martínez-Cartró M, Scaffidi S, Rachman M, Rodriguez-Arevalo S, Sanchez-Arfelis A, Escolano C, Picaud S, Krojer T, Filippakopoulos P, von Delft F, Galdeano C, Barril X. PMID: 34898210.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    7. Fragment-to-lead tailored in silico design. Drug Discov Today Technol. 2021 Dec; 40:44-57. Rachman M, Piticchio S, Majewski M, Barril X. PMID: 34916022.
      View in: PubMed   Mentions: 4     Fields:    
    8. Discovery of an Allosteric Ligand Binding Site in SMYD3 Lysine Methyltransferase. Chembiochem. 2021 05 04; 22(9):1597-1608. Talibov VO, Fabini E, FitzGerald EA, Tedesco D, Cederfeldt D, Talu MJ, Rachman MM, Mihalic F, Manoni E, Naldi M, Sanese P, Forte G, Lepore Signorile M, Barril X, Simone C, Bartolini M, Dobritzsch D, Del Rio A, Danielson UH. PMID: 33400854; PMCID: PMC8248052.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    9. Discovery of a novel kinase hinge binder fragment by dynamic undocking. RSC Med Chem. 2020 May 01; 11(5):552-558. Rachman M, Bajusz D, Hetényi A, Scarpino A, Mero B, Egyed A, Buday L, Barril X, Keseru GM. PMID: 33479656; PMCID: PMC7593776.
      View in: PubMed   Mentions: 6  
    10. DUckCov: a Dynamic Undocking-Based Virtual Screening Protocol for Covalent Binders. ChemMedChem. 2019 05 17; 14(10):1011-1021. Rachman M, Scarpino A, Bajusz D, Pálfy G, Vida I, Perczel A, Barril X, Keseru GM. PMID: 30786178; PMCID: PMC6593427.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    11. Predicting how drug molecules bind to their protein targets. Curr Opin Pharmacol. 2018 10; 42:34-39. Rachman MM, Barril X, Hubbard RE. PMID: 30041063.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    Moira's Networks
    Concepts (40)
    Derived automatically from this person's publications.
    _
    Co-Authors (12)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _